These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19729904)

  • 1. Etanercept clearance during an in vitro model of continuous venovenous hemofiltration.
    Fleming GM; Salama NN; Eid SK; Cooke KR; Mueller BA
    Blood Purif; 2009; 28(4):348-53. PubMed ID: 19729904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoglobin clearance and removal during continuous venovenous hemofiltration.
    Amyot SL; Leblanc M; Thibeault Y; Geadah D; Cardinal J
    Intensive Care Med; 1999 Oct; 25(10):1169-72. PubMed ID: 10551978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock.
    Rogiers P; Zhang H; Pauwels D; Vincent JL
    Crit Care Med; 2003 Apr; 31(4):1219-25. PubMed ID: 12682496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo Rezafungin Adsorption and Clearance During Continuous Renal Replacement Therapy.
    Jang SM; Hough G; Mueller BA
    Blood Purif; 2018; 46(3):214-219. PubMed ID: 30048960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters.
    Hiraiwa T; Moriyama K; Matsumoto K; Shimomura Y; Kato Y; Yamashita C; Hara Y; Kawaji T; Kurimoto Y; Nakamura T; Kuriyama N; Shibata J; Komura H; Morita K; Nishida O
    Blood Purif; 2020; 49(3):295-301. PubMed ID: 31995801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption of amikacin, a significant mechanism of elimination by hemofiltration.
    Tian Q; Gomersall CD; Ip M; Tan PE; Joynt GM; Choi GY
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1009-13. PubMed ID: 18086842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
    Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
    Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of ionic interactions in cytokine adsorption of polyethyleneimine-coated polyacrylonitrile and polymethyl methacrylate membranes in vitro.
    Moriyama K; Kato Y; Hasegawa D; Kurimoto Y; Kawaji T; Nakamura T; Kuriyama N; Shimomura Y; Nishida O
    J Artif Organs; 2020 Sep; 23(3):240-246. PubMed ID: 32394409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis.
    Matzke GR; Frye RF; Joy MS; Palevsky PM
    Pharmacotherapy; 2000 Jun; 20(6):635-43. PubMed ID: 10853618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study.
    Patel JH; Churchwell MD; Seroogy JD; Barriere SL; Grio M; Mueller B
    Int J Artif Organs; 2009 Oct; 32(10):745-51. PubMed ID: 19943236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy.
    Lewis SJ; Switaj LA; Mueller BA
    Blood Purif; 2015; 40(1):66-71. PubMed ID: 26138225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo Elimination of Clonidine by Continuous Venovenous Hemofiltration in Critically Ill Patients.
    van den Oever HLA; Zeeman M; Nassikovker P; Bles C; van Steveninck FAL; de Meijer AR; Kruisdijk-Gerritsen A; Arbouw M
    Blood Purif; 2020; 49(5):622-626. PubMed ID: 31962323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin elimination by CVVH in vitro: evaluation of factors influencing sieving and membrane adsorption.
    Wagner CC; Steiner I; Zeitlinger M
    Int J Clin Pharmacol Ther; 2009 Mar; 47(3):178-86. PubMed ID: 19281727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Matzke GR; Frye RF; Joy MS; Palevsky PM
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1639-44. PubMed ID: 10817721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes.
    Bouman CS; van Olden RW; Stoutenbeek CP
    Blood Purif; 1998; 16(5):261-8. PubMed ID: 9917534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
    Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
    Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient.
    Arzuaga A; Isla A; Gascón AR; Maynar J; Corral E; Pedraz JL
    Blood Purif; 2006; 24(4):347-54. PubMed ID: 16645266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.